Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome

  Free Subscription


22.08.2022

1 Am J Gastroenterol
1 Animal Model Exp Med
1 Ann Intern Med
1 Biochim Biophys Acta Mol Basis Dis
1 BMC Med
1 Clin Gastroenterol Hepatol
1 Clin Nutr
1 Clin Transl Gastroenterol
1 Dig Dis
1 Evid Based Complement Alternat Med
1 Front Mol Neurosci
1 Front Nutr
1 Int J Mol Sci
1 J Ethnopharmacol
1 J Pediatr Gastroenterol Nutr
1 J Toxicol Environ Health B Crit Rev
1 Medicine (Baltimore)
1 Microb Cell Fact
1 Neurogastroenterol Motil
1 Pain
1 Recent Pat Biotechnol
1 Therap Adv Gastroenterol
1 United European Gastroenterol J
2 World J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. HUANG Z, Lin Z, Lin C, Chu H, et al
    Transcutaneous Electrical Acustimulation Improves Irritable Bowel Syndrome with Constipation by Accelerating Colon Transit and Reducing Rectal Sensation via Autonomic Mechanisms.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00418.
    PubMed         Abstract available


    Animal Model Exp Med

  2. FU Q, Song T, Ma X, Cui J, et al
    Research progress on the relationship between intestinal microecology and intestinal bowel disease.
    Animal Model Exp Med. 2022 Aug 12. doi: 10.1002/ame2.12262.
    PubMed         Abstract available


    Ann Intern Med

  3. COX JF 3RD
    In IBS, a smartphone application for self-managing a FODMAP-lowering diet vs. otilonium bromide reduced symptoms at 8 wk.
    Ann Intern Med. 2022;175:JC91.
    PubMed         Abstract available


    Biochim Biophys Acta Mol Basis Dis

  4. HUSEIN DM, Rizk S, Hoter AU, Wanes D, et al
    Severe pathogenic variants of intestinal sucrase-isomaltase interact avidly with the wild type enzyme and negatively impact its function and trafficking.
    Biochim Biophys Acta Mol Basis Dis. 2022 Aug 16:166523.
    PubMed         Abstract available


    BMC Med

  5. BILBAO A, Spanagel R
    Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
    BMC Med. 2022;20:259.
    PubMed         Abstract available


    Clin Gastroenterol Hepatol

  6. SHIN A, Xu H, Imperiale TF
    The Prevalence, Humanistic Burden, and Healthcare Impact of Irritable Bowel Syndrome (IBS) Among United States Veterans.
    Clin Gastroenterol Hepatol. 2022 Aug 11. pii: S1542-3565(22)00769.
    PubMed         Abstract available


    Clin Nutr

  7. BISCHOFF SC, Barazzoni R, Busetto L, Campmans-Kuijpers M, et al
    European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint ESPEN/UEG guideline.
    Clin Nutr. 2022 Aug 11. pii: S0261-5614(22)00239.
    PubMed         Abstract available


    Clin Transl Gastroenterol

  8. YU C, Tovar S, Shi J, Padilla A, et al
    SATISFACTION WITH TELEHEALTH AMONG PATIENTS WITH IRRITABLE BOWEL SYNDROME DURING COVID-19: CROSS-SECTIONAL SURVEY FINDINGS.
    Clin Transl Gastroenterol. 2022 Aug 18. pii: 01720094-990000000-00079.
    PubMed         Abstract available


    Dig Dis

  9. NAKOV R, Velikova T, Dimitrova-Yurukova D, Snegarova V, et al
    Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Bulgaria: an internet-based survey.
    Dig Dis. 2022 Aug 16. pii: 000526355. doi: 10.1159/000526355.
    PubMed         Abstract available


    Evid Based Complement Alternat Med

  10. HE S, Lin Q, Huang J, Zheng L, et al
    Effect and Mechanism of Flavored Tongxie Yaofang Decoction for Diarrheal Irritable Bowel Syndrome under Intestinal Microecology.
    Evid Based Complement Alternat Med. 2022;2022:3904571.
    PubMed         Abstract available


    Front Mol Neurosci

  11. WANG J, Duan G, Zhan T, Dong Z, et al
    Upregulation of Netrin-1 in the hippocampus mediates the formation of visceral hypersensitivity induced by maternal separation.
    Front Mol Neurosci. 2022;15:908911.
    PubMed         Abstract available


    Front Nutr

  12. SCHELL KR, Fernandes KE, Shanahan E, Wilson I, et al
    The Potential of Honey as a Prebiotic Food to Re-engineer the Gut Microbiome Toward a Healthy State.
    Front Nutr. 2022;9:957932.
    PubMed         Abstract available


    Int J Mol Sci

  13. BERTUCCIOLI A, Cardinali M, Di Pierro F, Zonzini GB, et al
    Ketogenic and Low FODMAP Diet in Therapeutic Management of a Young Autistic Patient with Epilepsy and Dysmetabolism Poorly Responsive to Therapies: Clinical Response and Effects of Intestinal Microbiota.
    Int J Mol Sci. 2022;23.
    PubMed         Abstract available


    J Ethnopharmacol

  14. ZHONG P, Zhou J, Fan YT, Guo MF, et al
    Co-existing polysaccharides affect the systemic exposure of major bioactive ingredients in Chang-Kang-Fang, a multi-herb prescription for treatment of irritable bowel syndrome.
    J Ethnopharmacol. 2022;298:115601.
    PubMed         Abstract available


    J Pediatr Gastroenterol Nutr

  15. RIZVI SA, Oriala C, Thomas J, Li S, et al
    Identifying Mast Cells in Gastrointestinal Biopsies in Pediatric Irritable Bowel Patients.
    J Pediatr Gastroenterol Nutr. 2022 Aug 17. pii: 00005176-990000000-00147.
    PubMed         Abstract available


    J Toxicol Environ Health B Crit Rev

  16. ROACH K, Roberts J
    A comprehensive summary of disease variants implicated in metal allergy.
    J Toxicol Environ Health B Crit Rev. 2022.
    PubMed         Abstract available


    Medicine (Baltimore)

  17. JADALLAH KA, Khatatbeh MM, Sarsak EW, Sweidan AN, et al
    Irritable bowel syndrome and its associated factors among Jordanian medical students: A cross-sectional study.
    Medicine (Baltimore). 2022;101:e30134.
    PubMed         Abstract available


    Microb Cell Fact

  18. CHURA-CHAMBI RM, Farah CS, Morganti L
    Human growth hormone inclusion bodies present native-like secondary and tertiary structures which can be preserved by mild solubilization for refolding.
    Microb Cell Fact. 2022;21:164.
    PubMed         Abstract available


    Neurogastroenterol Motil

  19. LACY BE, King J, Shortino D, Schaumburg C, et al
    Efficacy and safety of vibegron for the treatment of irritable bowel syndrome in women: Results of a randomized, double-blind, placebo-controlled phase 2 trial.
    Neurogastroenterol Motil. 2022 Aug 16:e14448. doi: 10.1111/nmo.14448.
    PubMed         Abstract available


    Pain

  20. ADAM F, Jouet P, Sabate JM, Perrot S, et al
    The thermal grill illusion of pain in chronic pain patients: a clinical marker of central sensitization?
    Pain. 2022 Aug 15. pii: 00006396-990000000-00151.
    PubMed         Abstract available


    Recent Pat Biotechnol

  21. MOHAMED OA, Samir S, Omar H, Hassan EA, et al
    Lab-scale Preparation of Recombinant Human Insulin-like Growth Factor-1 in Escherichia coli and its Potential Safety on Normal Human Lung Cell Line.
    Recent Pat Biotechnol. 2022;16:266-280.
    PubMed         Abstract available


    Therap Adv Gastroenterol

  22. OHLSSON B
    Extraintestinal manifestations in irritable bowel syndrome: A systematic review.
    Therap Adv Gastroenterol. 2022;15:17562848221114558.
    PubMed         Abstract available


    United European Gastroenterol J

  23. HUANG IH, Schol J, Khatun R, Carbone F, et al
    Worldwide prevalence and burden of gastroparesis-like symptoms as defined by the United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.
    United European Gastroenterol J. 2022 Aug 19. doi: 10.1002/ueg2.12289.
    PubMed         Abstract available


    World J Gastroenterol

  24. DONG LW, Ma ZC, Fu J, Huang BL, et al
    Upregulated adenosine 2A receptor accelerates post-infectious irritable bowel syndrome by promoting CD4+ T cells' T helper 17 polarization.
    World J Gastroenterol. 2022;28:2955-2967.
    PubMed         Abstract available

  25. MOUREY F, Decherf A, Jeanne JF, Clement-Ziza M, et al
    Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation.
    World J Gastroenterol. 2022;28:2509-2522.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: